PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2680
https://www.valueinhealthjournal.com/article/S1098-3015(23)05810-2/fulltext
Title :
PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05810-2&doi=10.1016/j.jval.2023.09.2680
First page :
Section Title :
Open access? :
No
Section Order :
12012